Prolonged controlled mechanical ventilation in humans triggers myofibrillar contractile dysfunction and myofilament protein loss in the diaphragm

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

BACKGROUND: Prolonged controlled mechanical ventilation (CMV) in humans and experimental animals results in diaphragm fibre atrophy and injury. In animals, prolonged CMV also triggers significant declines in diaphragm myofibril contractility. In humans, the impact of prolonged CMV on myofibril contractility remains unknown. The objective of this study was to evaluate the effects of prolonged CMV on active and passive human diaphragm myofibrillar force generation and myofilament protein levels.

METHODS AND RESULTS: Diaphragm biopsies were obtained from 13 subjects undergoing cardiac surgery (control group) and 12 brain-dead organ donors (CMV group). Subjects in each group had been mechanically ventilated for 2-4 and 12-74 h, respectively. Specific force generation of diaphragm myofibrils was measured with atomic force cantilevers. Rates of force development (Kact), force redevelopment after a shortening protocol (Ktr) and relaxation (Krel) in fully activated myofibrils (pCa(2+)=4.5) were calculated to assess myosin cross-bridge kinetics. Myofilament protein levels were measured with immunoblotting and specific antibodies. Prolonged CMV significantly decreased active and passive diaphragm myofibrillar force generation, Kact, Ktr and Krel. Myosin heavy chain (slow), troponin-C, troponin-I, troponin-T, tropomyosin and titin protein levels significantly decreased in response to prolonged CMV, but no effects on α-actin, α-actinin or nebulin levels were observed.

CONCLUSIONS: Prolonged CMV in humans triggers significant decreases in active and passive diaphragm myofibrillar force generation. This response is mediated, in part, by impaired myosin cross-bridge kinetics and decreased myofibrillar protein levels.

Errataetall:

CommentIn: Thorax. 2016 May;71(5):397-8. - PMID 27080355

Medienart:

E-Artikel

Erscheinungsjahr:

2016

Erschienen:

2016

Enthalten in:

Zur Gesamtaufnahme - volume:71

Enthalten in:

Thorax - 71(2016), 5 vom: 15. Mai, Seite 436-45

Sprache:

Englisch

Beteiligte Personen:

Hussain, Sabah N A [VerfasserIn]
Cornachione, Anabelle S [VerfasserIn]
Guichon, Céline [VerfasserIn]
Al Khunaizi, Auday [VerfasserIn]
Leite, Felipe de Souza [VerfasserIn]
Petrof, Basil J [VerfasserIn]
Mofarrahi, Mahroo [VerfasserIn]
Moroz, Nikolay [VerfasserIn]
de Varennes, Benoit [VerfasserIn]
Goldberg, Peter [VerfasserIn]
Rassier, Dilson E [VerfasserIn]

Links:

Volltext

Themen:

02X6KNJ5EE
11003-00-2
Actinin
Actins
Assisted Ventilation
Connectin
EC 3.6.4.1
Journal Article
Muscle Proteins
Myosin Heavy Chains
Nebulin
Research Support, Non-U.S. Gov't
Respiratory Muscles
Tropomyosin
Troponin C
Troponin I
Troponin T

Anmerkungen:

Date Completed 15.09.2016

Date Revised 02.12.2018

published: Print-Electronic

CommentIn: Thorax. 2016 May;71(5):397-8. - PMID 27080355

Citation Status MEDLINE

doi:

10.1136/thoraxjnl-2015-207559

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM258962585